Literature DB >> 1485030

The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics.

O Campollo1, D Sprengers, N McIntyre.   

Abstract

We studied the plasma amino acid profiles in the postabsorptive period in three groups of cirrhotic patients: stable, unstable, and with acute portal systemic encephalopathy (PSE), and compared them with a healthy control group in order to investigate the differences among the different groups and reevaluate the use of the branched-chain amino acid/aromatic amino acid (BCAA/AAA) ratio. Although plasma amino acid levels were similar to the control group, stable cirrhotics had a significantly decreased BCAA/AAA ratio (2.9 +/- 0.2) compared to the control group (3.9 +/- 0.3) (p < 0.05). Unstable cirrhotics had differences in plasma amino acid levels and the BCAA/AAA ratio was even lower (1.7 +/- 0.3) compared with stable cirrhotics and controls, respectively (p < 0.05 and p < 0.01). Patients with PSE had extreme elevations of most amino acids and showed the lowest BCAA/AAA ratio of all four groups (0.8 +/- 0.07) (p < 0.001 compared with controls). We conclude that it is possible to detect differences in plasma amino acid concentrations in different groups of cirrhotics, and that the BCAA/AAA ratio is a good index for the assessment of liver impairment. The latter could be used in the follow-up of a selected group of patients such as those undergoing major surgery or liver transplantation in whom the BCAA/AAA ratio could be used to help determine the best time for the transplant.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485030

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  14 in total

1.  Plasma amino acids in four models of experimental liver injury in rats.

Authors:  M Holeček; J Mráz; I Tilšer
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

2.  Profile of plasma amino Acid levels in rats exposed to acute hypoxic hypoxia.

Authors:  Haruhiro Muratsubaki; Akiko Yamaki
Journal:  Indian J Clin Biochem       Date:  2011-04-07

Review 3.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 4.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

5.  Minimal hepatic encephalopathy in children: evaluation with proton MR spectroscopy.

Authors:  B R Foerster; L S Conklin; M Petrou; P B Barker; K B Schwarz
Journal:  AJNR Am J Neuroradiol       Date:  2009-06-09       Impact factor: 3.825

6.  Protein tolerance to standard and high protein meals in patients with liver cirrhosis.

Authors:  Octavio Campollo; Dirk Sprengers; Gitte Dam; Hendrik Vilstrup; Neil McIntyre
Journal:  World J Hepatol       Date:  2017-05-18

7.  Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection.

Authors:  Guoxiang Xie; Xiaoning Wang; Runmin Wei; Jingye Wang; Aihua Zhao; Tianlu Chen; Yixing Wang; Hua Zhang; Zhun Xiao; Xinzhu Liu; Youping Deng; Linda Wong; Cynthia Rajani; Sandi Kwee; Hua Bian; Xin Gao; Ping Liu; Wei Jia
Journal:  BMC Med       Date:  2020-06-05       Impact factor: 8.775

8.  Metabonomics of d-glucaro-1,4-lactone in preventing diethylnitrosamine-induced liver cancer in rats.

Authors:  Wenlong Yang; Guanlin Zhou; Shubing Zou; Wentao Yang; Aihong Liu; Shuilin Sun; Baogang Xie
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

9.  Effects of a honeybee sting on the serum free amino acid profile in humans.

Authors:  Jan Matysiak; Paweł Dereziński; Agnieszka Klupczyńska; Joanna Matysiak; Elżbieta Kaczmarek; Zenon J Kokot
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

10.  Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning.

Authors:  Runmin Wei; Jingye Wang; Xiaoning Wang; Guoxiang Xie; Yixing Wang; Hua Zhang; Cheng-Yuan Peng; Cynthia Rajani; Sandi Kwee; Ping Liu; Wei Jia
Journal:  EBioMedicine       Date:  2018-08-10       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.